Objective Multiple sclerosis (MS) is a demyelinating disease of the central nervous system,
leading to memory impairment in up to 65% of patients. Memory dysfunction in MS has been …

To ensure efficient energy supply to the high demanding brain, nutrients are transported
into brain cells via specific glucose (GLUT) and monocarboxylate transporters (MCT). …

Background The symptoms of multiple sclerosis (MS) are caused by damage to myelin and
nerve cells in the brain and spinal cord. Inflammation is tightly linked with neurodegeneration…

Meningeal inflammation strongly associates with demyelination and neuronal loss in the
underlying cortex of progressive MS patients, thereby contributing significantly to clinical …

Traumatic brain injury (TBI) is a leading cause of mortality, sensorimotor morbidity, and
neurocognitive disability. Neuroinflammation is one of the key drivers causing secondary brain …

Subpial cortical demyelination is an important component of multiple sclerosis (MS) pathology
contributing to disease progression, yet mechanism (s) underlying its development remain …

Microglial clusters with C3d deposits are observed in the periplaque of multiple sclerosis (MS)
brains and were proposed as early stage of lesion formation. As such they should appear …

The complement system is a key driver of neuroinflammation. Activation of complement by
all pathways, results in the formation of the anaphylatoxin C5a and the membrane attack …

Aicardi–Goutières syndrome (AGS) is a monogenic inflammatory encephalopathy caused
by mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, or MDA5. …

Aims Focal cortical dysplasia (FCD) type 2 is an epileptogenic malformation of the neocortex
associated with somatic mutations in the mammalian target of rapamycin (mTOR) pathway. …